首页 | 本学科首页   官方微博 | 高级检索  
     

基于癌基因组图谱数据挖掘分析CC亚族趋化因子配体20在食管癌中的表达及临床意义
引用本文:秦波,王正洋,殷凡响,闫丹,朱珠. 基于癌基因组图谱数据挖掘分析CC亚族趋化因子配体20在食管癌中的表达及临床意义[J]. 解剖学报, 2022, 53(1): 60-65. DOI: 10.16098/j.issn.0529-1356.2022.01.008
作者姓名:秦波  王正洋  殷凡响  闫丹  朱珠
作者单位:1.郑州大学第一附属医院转化医学中心,郑州 450052; 2.郑州大学第一附属医院病理科,郑州 450052; 3.郑州大学第一附属医院生物样本库,郑州 450052
基金项目:国家自然科学基金青年基金(31801142);;河南省医学科技攻关联合共建项目(2018020094;2018020080);
摘    要:目的 探讨CC亚族趋化因子配体20(CCL20)在食管癌中的表达及对病程进展和预后的影响.方法 利用癌基因组图谱(TCGA)、UALCAN、GEO等相关数据库分析CCL20基因在食管癌组织与癌旁组织中的表达差异,通过Kaplan-Meier模型探讨CCL20表达水平与预后的关联性;分析CCL20与肥胖、甲基化等之间的关...

关 键 词:食管癌  CC亚族趋化因子配体20  癌基因组图谱数据库  预后  免疫组织化学  
收稿时间:2020-09-25
修稿时间:2020-12-22

Expression and clinical significance of CC motif chemokine ligand 20 in esophageal carcinoma based on the Cancer Genome Atlas data mining
QIN Bo,WANG Zheng-yang,YIN Fan-xiang,YAN Dan,ZHU Zhu. Expression and clinical significance of CC motif chemokine ligand 20 in esophageal carcinoma based on the Cancer Genome Atlas data mining[J]. Acta Anatomica Sinica, 2022, 53(1): 60-65. DOI: 10.16098/j.issn.0529-1356.2022.01.008
Authors:QIN Bo  WANG Zheng-yang  YIN Fan-xiang  YAN Dan  ZHU Zhu
Affiliation:1.Department of Translational Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China; 2.Department of Pathology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China; 3.Department of Biological Sample Bank, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Abstract:Objective To explore the expression and significance of CC mokif chemokine ligand 20(CCL20)gene in esophageal carcinoma and its influence on the progression and prognosis of the disease.Methods The expression data of esophageal cancer were obtained from the Cancer Genome Atlas(TCGA)database,and were collected from cBioPortal(www.cbioportal.org).The survival curve was analyzed by Kaplan-Meier method.Through the website(http://ualcan.path.uab.edu)the objective was to analyze the expression of CCL20 gene in esophageal cancer tissues,the relationship between CCL20 and obesity and the methylation level of CCL20 in esophageal cancer.cBioPortal was used to analyze the copy number and mRNA expression of CCL20 gene.Finally,the expression differences of CCL20 in esophageal cancer tissues and adjacent tissues were analyzed by mRNA and protein levels.Results CCL20 was highly expressed in esophageal cancer,especially adenocarcinoma.The survival rate of patients with high expression of CCL20 was reduced.The expression of CCL20 was directly proportional to the degree of obesity in patients with esophageal cancer and inversely proportional to the degree of methylation.The expression of CCL20 in esophageal cancer tissues increased significantly.Conclusion CCL20 gene expression level is associated with poor prognosis of esophageal cancer patients.
Keywords:Esophageal cancer  CC motif chemokine ligand 20  The Cancer Genome Atlas database  Prognosis  Immunohistochemistry  Human
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《解剖学报》浏览原始摘要信息
点击此处可从《解剖学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号